ONLY $9.90 DELIVERY INFO

Close Notification

Your cart does not contain any items

Resistance to Immunotoxins in Cancer Therapy

Rama Shanker Verma Benjamin Bonavida

$251.95   $201.58

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer International Publishing AG
27 June 2015
This book will be a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. It contains a detailed review of the history and development of targeted therapy. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance. Each chapter discusses different aspects of resistance and covers all the factors that may contribute to resistance in cancer cells. Finally, this volume highlights the recent findings and advances associated with tackling cancer resistance.
Edited by:   ,
Imprint:   Springer International Publishing AG
Country of Publication:   Switzerland
Edition:   2015 ed.
Volume:   6
Dimensions:   Height: 235mm,  Width: 155mm,  Spine: 16mm
Weight:   5.266kg
ISBN:   9783319172743
ISBN 10:   3319172743
Series:   Resistance to Targeted Anti-Cancer Therapeutics
Pages:   249
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Rama Shanker Verma, Ph.D., is Professor, Department of Biotechnology, the Indian Institute of Technology. Professor Verma specializes in the development of novel immunotoxins for cancer therapies. He has published 76 scientific articles, five book chapters, and several conference abstracts. He is an Elected Fellow, the Association of Microbiologists of India an Elected Fellow, the Society for Applied Biotechnology. He received the award for Excellence in Medical Biotechnology from the Society for Applied Biotechnology.

See Also